Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O L Laskin

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
The American Journal of Medicine|July 20, 1982
Effect of renal failure on the pharmacokinetics of acyclovirO L Laskin, J A Longstreth, A Whelton, et al.
The New England Journal of Medicine|May 15, 1980
Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycinC R Smith, J J Lipsky, O L Laskin, et al.
Journal of Medical Virology|January 1, 1993
Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysisJ C Huff, J L Drucker, A Clemmer, et al.
Clinical Pharmacology and Therapeutics|May 1, 1987
Ribavirin disposition in high-risk patients for acquired immunodeficiency syndromeO L Laskin, J A Longstreth, C C Hart, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1982
Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humansO L Laskin, P de Miranda, D H King, et al.
Clinical Pharmacology and Therapeutics|January 1, 1994
Pharmacodynamics of MK-0963, a new 5 alpha-reductase inhibitor: effects on serum androgen concentrationsJ I Schwartz, O L Laskin, C A Meeter, et al.
The American Journal of Medicine|August 29, 1988
Therapy of herpes zoster with oral acyclovirJ C Huff, B Bean, H H Balfour, et al.
The New England Journal of Medicine|October 7, 1993
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working GroupM S Saag, E A Emini, O L Laskin, et al.
JAMA|November 3, 1989
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working GroupM A Fischl, D D Richman, D M Causey, et al.
The New England Journal of Medicine|July 23, 1987
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialD D Richman, M A Fischl, M H Grieco, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
The American Journal of Medicine|July 20, 1982
Effect of renal failure on the pharmacokinetics of acyclovirO L Laskin, J A Longstreth, A Whelton, et al.
The New England Journal of Medicine|May 15, 1980
Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycinC R Smith, J J Lipsky, O L Laskin, et al.
Journal of Medical Virology|January 1, 1993
Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysisJ C Huff, J L Drucker, A Clemmer, et al.
Clinical Pharmacology and Therapeutics|May 1, 1987
Ribavirin disposition in high-risk patients for acquired immunodeficiency syndromeO L Laskin, J A Longstreth, C C Hart, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1982
Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humansO L Laskin, P de Miranda, D H King, et al.
Clinical Pharmacology and Therapeutics|January 1, 1994
Pharmacodynamics of MK-0963, a new 5 alpha-reductase inhibitor: effects on serum androgen concentrationsJ I Schwartz, O L Laskin, C A Meeter, et al.
The American Journal of Medicine|August 29, 1988
Therapy of herpes zoster with oral acyclovirJ C Huff, B Bean, H H Balfour, et al.
The New England Journal of Medicine|October 7, 1993
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working GroupM S Saag, E A Emini, O L Laskin, et al.
JAMA|November 3, 1989
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working GroupM A Fischl, D D Richman, D M Causey, et al.
The New England Journal of Medicine|July 23, 1987
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trialD D Richman, M A Fischl, M H Grieco, et al.
Pageof 5